Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimens
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Journal of Virological Methods
- Vol. 290, 114092
Abstract
No abstract availableKeywords
Funding Information
- National Science and Technology Development Agency (P-17-51377)
- National Research Council of Thailand
- Faculty of Medicine, Chulalongkorn University (P0)002/63)
- Chulalongkorn University
- Thailand Research Fund (RSA6180035)
This publication has 9 references indexed in Scilit:
- Detection of SARS-CoV-2 with SHERLOCK One-Pot TestingNew England Journal of Medicine, 2020
- Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assayNature Communications, 2020
- Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and ChallengesiScience, 2020
- Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport MediumThe Journal of Molecular Diagnostics, 2020
- COVID-19 infection: Emergence, transmission, and characteristics of human coronavirusesJournal of Advanced Research, 2020
- Overcoming the bottleneck to widespread testing: a rapid review of nucleic acid testing approaches for COVID-19 detectionRNA, 2020
- Towards better base editingNature Biomedical Engineering, 2020
- When the world needs to knowNature Biotechnology, 2020
- DNA Detection Using Recombination ProteinsPLOS Biology, 2006